WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'5501 Infant (under 12 months) mortality rate: 742
GDP / capita (US$): 2'5861 Child (under 5 years) mortality rate: 1002

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 2'074  2'052  2'030  2'009  1'990  1'856  1'598  1'307 
Births 57  57  57  56  56  58  57  54 
Surviving infants 54  53  53  52  52  53  52  48 
Pop. less than 5 years 262  260  257  253  251  270  253  224 
Pop. less than 15 years 754  755  756  756  757  765  702  580 
Female 15-49 years 534  523  514  505  497  455  364  315 

Number of reported case

(Click for retrospective incidence data for Lesotho)
Diphtheria 37  13 
Japanese encephalitis
Measles 516  179  172  2'488  660  2'195  7'935 
Mumps
Pertussis 34  2'020 
Polio* 36 
Rubella 516  68  172 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total) 27 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Lesotho)
Vaccine year result method % card seen                                                
BCG 2008  95  DHS   74  65  68  68  80  73 
DTP1 2008  96  DHS   74  69  69  71  85  75 
DTP3 2008  84  DHS   74  66  67  69  75  72  69  71 
HepB_BD         
HepB3 2003  14  DHS   78  66  67  69  75  72 
Hib3          66  67  69  75  72 
JapEnc         
MCV 2008  80  DHS   74  61  60  61  70  70  80 
MCV2          70 
PCV1         
PCV3         
Pol3 2008  75  DHS   74  66  66  69  73  72  67  73 
Rota1         
Rota_last         
Rubella1         
TT2plus 1995  89  MICS   75  39  36  57  80  65 
PAB         
VAD1          55 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Lesotho)
BCG 87  87  87  90  92  88  89  81 
DTP1 97  97  97  97  96  87  91  75 
DTP3 96  96  96  93  91  83  82  56 
HepB3 96  96  96  93  91 
HepB_BD
Hib3 96  96  96  94  91 
MCV 92  92  92  88  84  74  80  49 
MCV2 82  82  82  81  81 
PAB 83  83  83  83  83  73 
PCV3
Pol3 95  95  95  92  89  82  82  56 
Rota_last

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 80
Less than 50% 20
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 18 months; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9-13 years Yes 3 doses
Measles 9, 18 months; Yes
OPV 6, 10, 14 weeks; Yes
Pneumo_conj Yes From August 2014
Rotavirus Yes From August 2014
TT pregnant women; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 10  10  19 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  Yes       

System performance

Total Nº districts in country number 10  10  10  10  10  10  19 
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 10  10  20  30  50 
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100%  

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  No  No  No  No  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 54    42   

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.